Asset Details
Do you wish to reserve the book?
Impact of cachexia on outcomes in aggressive lymphomas
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Impact of cachexia on outcomes in aggressive lymphomas
Do you wish to request the book?
Impact of cachexia on outcomes in aggressive lymphomas
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Impact of cachexia on outcomes in aggressive lymphomas
2017
Overview
Cancer cachexia is defined as a state of involuntary weight loss, attributed to altered body composition with muscle mass loss and/or loss of adiposity. Identifying the association between cancer cachexia and outcomes may pave the way for novel agents that target the cancer cachexia process. Clinical parameters for measurement of cancer cachexia are needed. We conducted a single-institution retrospective analysis that included 86 NHL patients with the aim of identifying an association between cancer cachexia and outcomes in aggressive lymphomas using the cachexia index (CXI) suggested by Jafri et al. (Clin Med Insights Oncol 9:87–93,
15
). Impact of cachexia factors on progression-free survival (PFS) and overall survival (OS) were assessed using log-rank test and Cox proportional hazards regression. Patients were dichotomized around the median CXI into “non-cachectic” (CXI ≥49.8,
n
= 41) and “cachectic” (CXI <49.8,
n
= 40) groups. Cachectic patients had significantly worse PFS (HR 2.18,
p
= 0.044) and OS (HR = 4.05,
p
= 0.004) than non-cachectic patients. Cachexia as defined by the CXI is prognostic in aggressive lymphomas and implies that novel therapeutic strategies directed at reversing cachexia may improve survival in this population.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
/ Female
/ Humans
/ Lymphoma, Large B-Cell, Diffuse - complications
/ Lymphoma, Large B-Cell, Diffuse - drug therapy
/ Lymphoma, Large B-Cell, Diffuse - physiopathology
/ Lymphoma, Non-Hodgkin - complications
/ Lymphoma, Non-Hodgkin - drug therapy
/ Lymphoma, Non-Hodgkin - physiopathology
/ Male
/ Medicine
/ Oncology
/ Outcome Assessment (Health Care) - methods
/ Outcome Assessment (Health Care) - statistics & numerical data
